NL8104832A - Nieuwe beta-galactosidase-remmer. - Google Patents
Nieuwe beta-galactosidase-remmer. Download PDFInfo
- Publication number
- NL8104832A NL8104832A NL8104832A NL8104832A NL8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A
- Authority
- NL
- Netherlands
- Prior art keywords
- galactosidase
- activity
- pharmaceutically acceptable
- enzyme
- methanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15092780 | 1980-10-27 | ||
JP55150927A JPS5774090A (en) | 1980-10-27 | 1980-10-27 | Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8104832A true NL8104832A (nl) | 1982-05-17 |
Family
ID=15507444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8104832A NL8104832A (nl) | 1980-10-27 | 1981-10-26 | Nieuwe beta-galactosidase-remmer. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4497797A (fr) |
JP (1) | JPS5774090A (fr) |
DE (1) | DE3142400A1 (fr) |
FR (1) | FR2492664A1 (fr) |
GB (1) | GB2086394B (fr) |
NL (1) | NL8104832A (fr) |
NZ (1) | NZ198680A (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0684377B1 (fr) * | 1986-04-17 | 1994-10-26 | Kyowa Hakko Kogyo Kk | |
EP0313846B1 (fr) * | 1987-10-29 | 1994-05-04 | American Cyanamid Company | Méthode de contrôle de maladies chroniques respiratoires, et d entérites nérotiques chez les oiseaux |
US5179023A (en) * | 1989-03-24 | 1993-01-12 | Research Corporation Technologies, Inc. | Recombinant α-galactosidase a therapy for Fabry disease |
AU702122B2 (en) * | 1994-10-25 | 1999-02-11 | Merck & Co., Inc. | Microbial synthesis of HIV protease inhibitors |
US6210666B1 (en) | 1997-10-21 | 2001-04-03 | Orphan Medical, Inc. | Truncated α-galactosidase A to treat fabry disease |
CN103502458B (zh) | 2011-02-17 | 2016-11-16 | 宾夕法尼亚大学托管会 | 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法 |
CN106687596A (zh) * | 2014-02-17 | 2017-05-17 | 葛兰素史密斯克莱知识产权发展有限公司 | 微生物学方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3160560A (en) * | 1957-08-23 | 1964-12-08 | Upjohn Co | Streptolydigin and production thereof |
JPS5134916B2 (fr) * | 1974-03-06 | 1976-09-29 | ||
US3991183A (en) * | 1975-05-01 | 1976-11-09 | Pfizer Inc. | Antibiotic produced by a species of micromonospora |
-
1980
- 1980-10-27 JP JP55150927A patent/JPS5774090A/ja active Pending
-
1981
- 1981-10-19 NZ NZ198680A patent/NZ198680A/en unknown
- 1981-10-26 FR FR8120049A patent/FR2492664A1/fr active Granted
- 1981-10-26 NL NL8104832A patent/NL8104832A/nl not_active Application Discontinuation
- 1981-10-26 DE DE19813142400 patent/DE3142400A1/de not_active Withdrawn
- 1981-10-27 GB GB8132382A patent/GB2086394B/en not_active Expired
-
1982
- 1982-06-29 US US06/393,506 patent/US4497797A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ198680A (en) | 1985-04-30 |
GB2086394A (en) | 1982-05-12 |
GB2086394B (en) | 1984-03-07 |
JPS5774090A (en) | 1982-05-10 |
US4497797A (en) | 1985-02-05 |
FR2492664A1 (fr) | 1982-04-30 |
DE3142400A1 (de) | 1982-11-25 |
FR2492664B1 (fr) | 1985-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4254256A (en) | Amino sugar compound | |
US4460765A (en) | Enzyme inhibitor produced by cultivation of streptomyces microorganisms | |
SE468482B (sv) | Framstaellning av monakolin k | |
EP0182315A2 (fr) | Antibiotique NK84-0218, compositions pharmaceutiques le contenant et procédé pour sa production | |
CA1153966A (fr) | Ebelactone, substance ayant une action physiologique et methode de production | |
NL8104832A (nl) | Nieuwe beta-galactosidase-remmer. | |
AU7677600A (en) | Process for the preparation of mycophenolic acid and derivatives thereof | |
EP0019302A1 (fr) | Composés tétracycliques, procédés pour leur préparation, leur utilisation et compositions pharmaceutiques | |
DE2109854B2 (de) | 7beta-(D-5-Amino-5-carboxy valeramido)-3-(carbamoyloxymethyl>7-methoxy-3-cephem-4-carbonsäure und deren Salze, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel | |
CH618606A5 (fr) | ||
EP0317292B1 (fr) | Antibiotiques du groupe muréidomycine, leur préparation et leur emploi | |
US5039663A (en) | Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic use | |
US4197292A (en) | Novel amylase inhibitors | |
US4011140A (en) | Process for producing antitumor compound | |
US3974035A (en) | Process for preparing a cephamycin type antibiotic substance | |
JP2592468B2 (ja) | 新規抗生物質ベナノマイシンaおよびbならびにその製造法 | |
JPS5823077B2 (ja) | 抗生物質am−3603およびその製造方法 | |
US3825660A (en) | Antibiotic no.156 and process for producing the same | |
US4661352A (en) | WS 7739 substances, their preparation and pharmaceutical composition containing the same | |
JPH0578322A (ja) | 新規抗生物質sf2738物質及びその製造法並びに制癌剤 | |
US4242327A (en) | Antibiotic SF-2052 substance and production and use thereof | |
US4803074A (en) | FR-900848 substance and preparation thereof | |
CA1077421A (fr) | Antibiotique sf-1540 produit par un streptomyces | |
US3857756A (en) | Process for production of antibiotic | |
DE69300658T2 (de) | Anthracyclin Analogon, Verbindung UCEG. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |